WASHINGTON — The Consumer Healthcare Products Association (CHPA) issued the following statement from president and CEO Scott Melville regarding the Food and Drug Administration’s (FDA) fiscal year 2023 budget request:

Scott Melville

“FDA’s recent request for a 34 percent budget increase in FY2023 shows that new FDA Commissioner Robert Califf recognizes the critical importance of self-care in public health. FDA’s budget aligns with CHPA’s priorities to empower self-care by ensuring Americans continue to have access to safe, reliable, and affordable personal healthcare products including over-the-counter medicines, consumer medical devices, and dietary supplements.

“Specifically, we’re pleased to see FDA’s proposed budget also prioritizes modernization of dietary supplement regulation by supporting mandatory product listing, increasing inspection capacity, and clarifying its authority to better facilitate enforcement against unlawfully marketed products. This budget proposal makes it clear that Dr. Califf views stronger oversight of dietary supplements as a key part of FDA’s mission to advance the health and wellbeing of every American.

“We look forward to working with FDA and Congress as they map out the path forward for FY2023 and continue to empower consumer self-care.”